Homepage
Policies & Regulations
FDA-accelerated approval updates
January 17, 2025
Medical Policy

​​Independence Blue Cross (IBX) provides coverage for drugs, biologics, and gene therapies that have received FDA-accelerated approval when research findings demonstrate direct evidence of their clinical effectiveness. Starting January 1, 2025, IBX is clarifying its continued non-coverage position for certain drugs, biologics, and gene therapies that have received FDA-accelerated approval without demonstrating clinical findings that show effectiveness. In these cases, it is typical for the FDA to require continued research studies to demonstrate clinical effectiveness and proven safety of the treatment.

Claims & Billing
New ID cards to be issued for members transitioning to the new platform on February 1, 2025 – be sure to use new ID numbers
February 3, 2025
Submitting Claims
We continue to transition members in group plans to our new operating platform each month upon their renewal date. Members will receive a new member ID card upon their transition.
Programs
Isaac Health offers specialist dementia care
January 29, 2025
Member Programs
​With dementia rapidly on the rise, early diagnosis and ongoing care are more critical than ever. That is why Independence Blue Cross (IBX) has teamed up with Isaac Health to provide your patients (our members) with easier access to specialist dementia care and support.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




Filter to find the news that is relevant to your role.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




       
            Loading...